Clinical Trial Update: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a PD-1 inhibitor with chemotherapy and concurrent irradiation for advanced non-small cell lung cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• PD-1 inhibitor

Snippet

Sponsor: UNICANCER | Conditions: Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING